Abstract
Introduction
The purpose of this study was to evaluate the prevalence of sarcopenia in a cohort of healthy community-dwelling elderly in an urban area in Barcelona (Spain) for native benchmarks and compare them with those published in other geographical areas.
Material and methods
We prospectively evaluated a series of 200 healthy elderly in the community with preserved functional capacity and absence of cognitive impairment. We performed a comprehensive geriatric assessment and determined anthropometric data, muscle mass (MM) and the muscle mass index (MMI). Assessment of muscle mass was performed by bioelectrical impedance analysis (BIA). The cut-off point for defining sarcopenia MMI was established as less than 2 SD of the mean of a reference group comprising 220 healthy volunteers (20–42 years) in the same area. Results were compared with studies undertaken in the USA, France and Taiwan.
Results
The cut-off points obtained were 8.31 Kg/m2 for men and 6.68 Kg/m2 for women, being similar to those observed in France and Taiwan but different from the USA. The prevalence of sarcopenia observed was 33% for elderly women and 10% for males. On comparison of the prevalence of sarcopenia in the four populations, we observed some differences, particularly in males.
Conclusions
We have defined reference values for sarcopenia, determined by BIA, in our setting. We also observed a remarkable prevalence of sarcopenia in the healthy elderly community, especially in females, showing some differences from those in other geographical regions.
Similar content being viewed by others
References
Goodpaster BH, Carlson CL, Visser M, Kelley DE, Scherzinger A, Harris TB et al. (2001) Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study. J Appl Physiol 90:2157–2165
Jansenn I, Heymsfield SB, Wang Z, Ross R. (2000) Skeletal muscle mass and distribution in 468 men and woman aged 18–88 yr. J Appl Physiol 89:81–88
Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini Ch, Di Iorio A et al. (2003) Age-related changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 95:1851–1860
Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ. (1999) Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev 107:123–136
Morley JE. (2008) Sarcopenia: diagnosis and treatment. J Nutr Health Aging 12:452–456
Rolland And, Czerwinski S, Van Kan GA, JE Morley, Cesari M, Onder G et al. (2008) Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging 12:433–450
Waters DL, Baumgartner RN, Garry PJ. (2000) Sarcopenia: current perspectives. J Nutr Health Aging 4:133–139
Rosenberg I. (1997) Sarcopenia: origins and clinical relevance. J Nutr 127:990S–991S
Roubenoff R. (2000) Sarcopenia: a major modifiable cause of frailty in the elderly. J Nutr Health Aging 4:140–142
Cruz-Jentoft AJ, Landi F, Topinkova E, Michel JP. (2010) Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 2010; 13:1–7
Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Sreekumaran NK. (2001) Sarcopenia. J Lab Clin Med 137:231–243
Woodrow G. (2009) Body composition analysis techniques in the aged adult: indications and limitations. Curr Opin Clin Nutr Metab Care 12:8–14
Proctor DN, O’Brien PC, Atkinson EJ, Nair KS. (1999) Comparison of techniques to estimate total body skeletal muscle mass in people of different age groups. Am J Physiol 277: E489–E495
Kim J, Wang Z, Heymsfield SB, Baumgartner RN, Gallagher D. (2002) Totalbody skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method. Am J Clin Nutr 76:378–383
Janssen I, Shepard DS, Katzmarzyk PT Roubenoff R. (2004) The healthcare cost of sarcopenia in the United States. J Am Geriatr Soc 52: 80–85.
Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross R et al. (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755–763.
Melton LJ, Khosla S, Riggs BL. (2000) Epidemiology of sarcopenia. Mayo Clin Proc 75S: S10–S13.
Castillo EM, Goodman-Gruen D, Kritz-Silverstein D et al. (2003) Sarcopenia in elderly men and women. The Rancho Bernardo Study. Am J Prev Med 25:226–231.
Wright EM, Royston P. (1999) Calculating reference intervals for laboratory measurements. Res Methods Stat 8:93–112.
Jenne-Steinmetz C, Welleck S. (2005) A New Approach to Sample Size Calculation for reference interval studies. Statist Med 24:3199–3212.
Janssen I, Heymsfield SB, Baumgartner RN, Ross R. (2000) Estimation of muscle mass by skeletal bioelectrical impedance analysis. J Appl Physiol 89:465–471.
Salinari S, Bertuzzi A, Mingrone G, Capristo G, Scarfone A, Greco AV et al. (2003) Bioimpedance analysis: a useful technique for assessing appendicular lean soft tissue mass and distribution. J Appl Physiol 94:1552–1556
Grau JM, Masanes F, Pedrol, Casademont J, Fernandez-Sola J, Urbano-Marquez A. (1993). Human immunodeficiency virus tipe1 infection and myopathy: clinical relevante of zidovudine therapy. Ann Neurol 34:206–211.
Tichet J, Vol S, Coxe D, Salle A, Berrut G, Ritz P. (2008) Prevalence of sarcopenia in the senior French population. J Nutr Health Aging 12:202–206.
Chien M, Huang T, Wu Y. (2008) Estimated prevalence of sarcopenia using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan. J Am Geriatr Soc 56:1710–1715.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al. (2010) Sarcopenia: European consensus on definition and diagnosis. Age Ageing 39:412–423.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Masanes Toran, F., Culla, A., Navarro-Gonzalez, M. et al. Prevalence of sarcopenia in healthy community-dwelling elderly in an urban area of Barcelona (Spain). J Nutr Health Aging 16, 184–187 (2012). https://doi.org/10.1007/s12603-011-0108-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-011-0108-3